Loading clinical trials...
Loading clinical trials...
Effect of Simvastatin on the Prognosis of Primary Sclerosing Cholangitis (PSC); A Randomized, Double-blind, Placebo Controlled Multicenter Study
Conditions
Interventions
Simvastatin 40mg
Placebo oral tablet
Locations
12
Sweden
Skåne Universitetssjukhus
Malmo, Skåne County, Sweden
Norrlands Universitetssjukhus
Umeå, Västerbotten County, Sweden
Sahlgrenska Universitetssjukhuset
Gothenburg, Västra Götaland County, Sweden
Sahlgrenska Universitetssjukhuset Östra
Gothenburg, Sweden
Karlstads centralsjukhus
Karlstad, Sweden
Skaraborgs sjukhus
Lidköping, Sweden
Start Date
October 1, 2020
Primary Completion Date
March 31, 2028
Completion Date
March 31, 2030
Last Updated
September 5, 2025
NCT04753996
NCT05750498
NCT05295680
NCT02137668
NCT05896137
NCT05740358
Lead Sponsor
Annika Bergquist
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions